These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. 5'-Deoxy congeners of 9-(3-amido-3-deoxy-beta-D-xylofuranosyl)-N(6)-cyclopentyladenine: new adenosine A(1) receptor antagonists and inverse agonists. Van Calenbergh S; Link A; Fujikawa S; de Ligt RA; Vanheusden V; Golisade A; Blaton NM; Rozenski J; IJzerman AP; Herdewijn P J Med Chem; 2002 Apr; 45(9):1845-52. PubMed ID: 11960496 [TBL] [Abstract][Full Text] [Related]
25. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations. Mlejnek P; Dolezel P; Frydrych I J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730 [TBL] [Abstract][Full Text] [Related]
26. Structure-activity relationships of 2-chloro-N6-substituted-4'-thioadenosine-5'-N,N-dialkyluronamides as human A3 adenosine receptor antagonists. Jeong LS; Lee HW; Kim HO; Tosh DK; Pal S; Choi WJ; Gao ZG; Patel AR; Williams W; Jacobson KA; Kim HD Bioorg Med Chem Lett; 2008 Mar; 18(5):1612-6. PubMed ID: 18255292 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and anti-renal fibrosis activity of conformationally locked truncated 2-hexynyl-N(6)-substituted-(N)-methanocarba-nucleosides as A3 adenosine receptor antagonists and partial agonists. Nayak A; Chandra G; Hwang I; Kim K; Hou X; Kim HO; Sahu PK; Roy KK; Yoo J; Lee Y; Cui M; Choi S; Moss SM; Phan K; Gao ZG; Ha H; Jacobson KA; Jeong LS J Med Chem; 2014 Feb; 57(4):1344-54. PubMed ID: 24456490 [TBL] [Abstract][Full Text] [Related]
28. A highly facile and efficient one-step synthesis of N6-adenosine and N6-2'-deoxyadenosine derivatives. Wan ZK; Binnun E; Wilson DP; Lee J Org Lett; 2005 Dec; 7(26):5877-80. PubMed ID: 16354089 [TBL] [Abstract][Full Text] [Related]
29. Purine (N)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A3 Adenosine Receptor Agonists. Tosh DK; Ciancetta A; Warnick E; O'Connor R; Chen Z; Gizewski E; Crane S; Gao ZG; Auchampach JA; Salvemini D; Jacobson KA J Med Chem; 2016 Apr; 59(7):3249-63. PubMed ID: 26890707 [TBL] [Abstract][Full Text] [Related]
30. Discovery of a new nucleoside template for human A3 adenosine receptor ligands: D-4'-thioadenosine derivatives without 4'-hydroxymethyl group as highly potent and selective antagonists. Jeong LS; Choe SA; Gunaga P; Kim HO; Lee HW; Lee SK; Tosh DK; Patel A; Palaniappan KK; Gao ZG; Jacobson KA; Moon HR J Med Chem; 2007 Jul; 50(14):3159-62. PubMed ID: 17555308 [TBL] [Abstract][Full Text] [Related]
31. Exploring the Role of N Petrelli R; Scortichini M; Kachler S; Boccella S; Cerchia C; Torquati I; Del Bello F; Salvemini D; Novellino E; Luongo L; Maione S; Jacobson KA; Lavecchia A; Klotz KN; Cappellacci L J Med Chem; 2017 May; 60(10):4327-4341. PubMed ID: 28447789 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of new N6-substituted adenosine-5'-N-methylcarboxamides as A3 adenosine receptor agonists. Devine SM; Gregg A; Figler H; McIntosh K; Urmaliya V; Linden J; Pouton CW; White PJ; Bottle SE; Scammells PJ Bioorg Med Chem; 2010 May; 18(9):3078-87. PubMed ID: 20385496 [TBL] [Abstract][Full Text] [Related]
33. A new synthetic route to (North)-methanocarba nucleosides designed as A3 adenosine receptor agonists. Joshi BV; Moon HR; Fettinger JC; Marquez VE; Jacobson KA J Org Chem; 2005 Jan; 70(2):439-47. PubMed ID: 15651784 [TBL] [Abstract][Full Text] [Related]
35. "Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists. Perreira M; Jiang JK; Klutz AM; Gao ZG; Shainberg A; Lu C; Thomas CJ; Jacobson KA J Med Chem; 2005 Jul; 48(15):4910-8. PubMed ID: 16033270 [TBL] [Abstract][Full Text] [Related]
36. Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor. Auchampach JA; Jin X; Wan TC; Caughey GH; Linden J Mol Pharmacol; 1997 Nov; 52(5):846-60. PubMed ID: 9351976 [TBL] [Abstract][Full Text] [Related]
37. Adenosine-5'-carboxaldehyde: a potent inhibitor of S-adenosyl-L-homocysteine hydrolase. Liu S; Wnuk SF; Yuan C; Robins MJ; Borchardt RT J Med Chem; 1993 Apr; 36(7):883-7. PubMed ID: 8464042 [TBL] [Abstract][Full Text] [Related]
38. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor. Ge ZD; Peart JN; Kreckler LM; Wan TC; Jacobson MA; Gross GJ; Auchampach JA J Pharmacol Exp Ther; 2006 Dec; 319(3):1200-10. PubMed ID: 16985166 [TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationships of new 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric enhancers of the A3 adenosine receptor. Göblyös A; Gao ZG; Brussee J; Connestari R; Santiago SN; Ye K; Ijzerman AP; Jacobson KA J Med Chem; 2006 Jun; 49(11):3354-61. PubMed ID: 16722654 [TBL] [Abstract][Full Text] [Related]
40. Substituted 4-phenylthiazoles: Development of potent and selective A Abdelrahman A; Yerande SG; Namasivayam V; Klapschinski TA; Alnouri MW; El-Tayeb A; Müller CE Eur J Med Chem; 2020 Jan; 186():111879. PubMed ID: 31780082 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]